The interesting thing about Ann Fyfe's career is not that she moved from journalism to advertising, then into hospitals, strategy and medical technology. It is that each move brought her closer to the place where language becomes infrastructure. A story can frame a problem. A plan can align an institution. But a room full of the right people, given permission to be candid, can change whether an idea survives.
In 2007, Fyfe was vice president of business development at El Camino Hospital in Mountain View. She had led the hospital's strategic-planning process and worked in the practical machinery of healthcare expansion. With El Camino Health Foundation president Jon Freidenberg, she proposed a nonprofit medtech incubator on the hospital campus. The concept joined three assets that were usually kept apart: a working community hospital, the experience of surgeon-inventor Thomas Fogarty, and early teams trying to turn medical ideas into companies.
The resulting Fogarty Institute for Innovation opened with two companies, HeartFlow and Niveus Medical. Fyfe became its launch chief executive. Fogarty served as mentor, educator and board member. The location did more than make a good origin story. It gave entrepreneurs a way to encounter the clinical environment before their assumptions hardened into products.
Before the incubator, she learned to translate
Fyfe came to the work sideways. Born in Iowa, she studied journalism at the University of Colorado. She hosted a television program and founded Shockey Hester Advertising. Her agency clients included a western-clothing maker, an irrigation company and an international food distributor. In 1978, at 28, she was recruited from Colorado to bring marketing practice into a San Francisco hospital.
Hospital marketing was still a young discipline. Fyfe entered when consumer research, audience segmentation and promotion were unusual tools for providers. She tested what people wanted from healthcare organizations and helped organize professional groups around the new field. She served on the American Marketing Association board, helped the association develop a healthcare section, and founded the Northern California Healthcare Marketing Association.
The journalist's habit of asking questions remained useful. So did the advertiser's attention to audience. But the work grew beyond campaigns. Fyfe held senior roles at Bay Area hospitals and health systems, including Stanford Hospital, Lucile Packard Children's Hospital and El Camino Hospital. Her remit widened into strategy and business development - the decisions about where an institution should go, what it should build and whom it needed beside it.
That phrase reveals her operating stance. “Bold” was not left as an inspirational adjective. It became a named category in a plan, attached to initiatives that executives could debate, resource and measure. El Camino's strategy included acquiring and reopening a Los Gatos hospital campus during a difficult economy. It also included the innovation institute that would place physicians and engineers in regular conversation.
The address was part of the product
Startup support is often described as a list: workspace, capital, advice, introductions. Medical devices make that list longer and more demanding. A team must understand the care setting, design for the people who will use the product, document safety, work through regulation, plan manufacturing and build a business that can carry all of it.
Fogarty's hospital-campus model made one part of that work tangible. Physicians were nearby. Clinical routines were not abstractions on a slide. Entrepreneurs could get earlier feedback, and experienced mentors could challenge a weak prototype before the team spent another year defending it. When HeartFlow moved from concept toward clinical validation, an executive involved with the company described the institute as its “gestational” and “nurturing” ground.
Fyfe put the benefit plainly: “We work with physicians every day. The interaction with the hospital has been invaluable.” Her contribution was not to play the inventor. It was to make the surrounding system more navigable for inventors. Proximity became access; access became feedback; feedback became a better chance to make the next decision with evidence.
The proposal
Fyfe and Freidenberg connect El Camino Hospital with Thomas Fogarty's mentoring vision.
Research capacity
A $4 million gift establishes the Taft Center for Clinical Research on the campus.
Regulatory dialogue
FDA reviewers spend a week with resident startups to understand early development constraints.
Industry partnership
Ethicon backs education and mentorship for the institute's medical-device innovators.
The Taft Center shows how Fyfe's connective work expanded. A $4 million gift from Edward and Pamela Taft funded clinical research infrastructure at El Camino. The institute would help run the program. For local physicians and study teams, the center created capacity. For innovators, it created a more direct path to disciplined clinical investigation. For donors, it translated generosity into an operating system rather than a ceremonial name.
Bring the constraint into the room
In 2015, Fogarty and the US Food and Drug Administration began an educational pilot. Reviewers from the agency's medical-device center spent a week at the institute, working with startups and seeing the costs, timelines and tradeoffs of early development. The companies, in turn, gained a clearer view of how regulatory decisions contribute to safer products.
The program embodied a useful principle: when two groups misunderstand each other's constraints, do not settle for louder correspondence. Create a shared learning environment. Fyfe called the institute a “living laboratory” for the exchange. The phrase was accurate because the startups were not case studies polished after the fact. They were active companies carrying unresolved problems.
That year, Fogarty also partnered with Ethicon. The surgical-device company supported educational programs and committed expertise and mentorship. An Edwards Lifesciences Foundation grant later added support for startups and internships. Each relationship addressed a different bottleneck: regulatory comprehension, industry knowledge, funding, education and talent.
Fyfe's own path helped her see that an ecosystem is not a crowd. It is a sequence of exchanges that produces better decisions. A clinician can identify a workflow problem. A mentor can question an assumption. A regulator can explain an evidence requirement. An industry partner can expose a manufacturing or commercialization gap. The institute's job was to make those exchanges happen early enough to matter.
Do not save practical feedback for the final validation step.
Turn “bold” from mood-board language into an explicit operating category.
Shared context can replace months of talking past another institution.
Useful support maps to the points where teams repeatedly stall.
The institution kept the pattern
Fyfe led Fogarty for five years. In 2016 the institute announced Andrew Cleeland as her successor, and its work continued under a later name, Fogarty Innovation. A 2025 account of the organization's history returned to the original decision by Fyfe and Freidenberg: join a forward-looking community hospital with an experienced inventor's instinct for mentorship.
The companies changed. The programs grew. Yet the original logic remained visible. Fogarty startups continued to work with El Camino clinicians and research staff. Companies including HeartFlow and later graduates used the hospital setting for clinical research. The useful part of the model was not a single cohort. It was a durable relationship between people delivering care and people designing tools for that environment.
After Fogarty, Fyfe's public record shows consulting and nonprofit governance. She chaired the board of the California Hospice Network when it was formed in 2019 and served on the board of Mission Hospice & Home Care. Her LinkedIn profile lists Ann Fyfe Consulting and a long trail of volunteer leadership, including Women Health Care Executives and the Ferolyn Fund Advisory Council.
Her career reads as a series of bridges, but “bridge builder” can sound too soft for the work. Bridges have load limits. They require an understanding of what moves across them and why each side will maintain the connection. Fyfe spent decades learning the languages on both banks: audiences and executives, hospitals and startups, donors and operators, inventors and regulators.
The lesson is less glamorous than disruption and more reusable. Good ideas rarely fail for lack of adjectives. They fail in the distance between disciplines, incentives and institutions. Fyfe helped shorten that distance. First with words, then with plans, and finally with a place where the people carrying different pieces of the problem could meet.